Botulinum Toxin Applications in Movement Disorders
Summary
Botulinum neurotoxin, a potent metalloprotease produced by Clostridium botulinum, inhibits acetylcholine release at the neuromuscular junction and has become a cornerstone in the management of hyperkinetic disorders. Since its initial approval for facial spasms and blepharospasm, therapeutic applications have expanded to include focal and segmental dystonias, spasticity of central origin, tremors, tics and other involuntary movements. Precision delivery, often guided by electromyography or ultrasonography, allows tailored dosing to affected muscles, maximising symptom relief while minimising adverse effects such as muscle weakness or dysphagia. Beyond its peripheral action, emerging evidence suggests that botulinum toxin may induce central neuromodulatory changes, opening avenues for novel indications. Its global significance is underscored by improvements in motor function, pain reduction and quality of life across diverse patient populations. Ongoing developments address immunogenicity, long-term responsiveness and formulation refinements to enhance safety and durability of effect.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Botulinum Toxin Applications in Movement Disorders publication trend
The graph below shows the total number of articles in botulinum toxin applications in movement disorders across all publications each year (not limited to Nature Index journals).
Technical terms
Botulinum neurotoxin: A protein toxin that blocks neurotransmitter release at peripheral nerve terminals, used therapeutically to reduce muscle overactivity.
Dystonia: A movement disorder characterised by sustained or intermittent muscle contractions causing abnormal postures or repetitive movements.
Spasticity: A motor disorder marked by a velocity-dependent increase in muscle tone due to upper motor neuron lesion.
Immunogenicity: The capacity of a substance, such as a therapeutic protein, to provoke an immune response resulting in antibody formation.
References
- Immunogenicity Associated with Botulinum Toxin Treatment. Toxins (2019).
- Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin. Frontiers in Neurology (2017).
- Botulinum Toxin in Movement Disorders: An Update. Toxins (2021).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.